Connect with us

Health

Europe pushes to regain ground on competitors with new Biotech Act

SHARE:

Published

7 months ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise.

The Biotech Act Regulation sets out a broad framework that combines investment, regulatory reform, artificial intelligence, and biosecurity safeguards, all aimed at ensuring that biotechnology breakthroughs are not only discovered in Europe but also developed and manufactured here.

At its core, the Act responds to Mario Draghi’s stark analysis that, despite Europe’s scientific excellence, global leadership in biotech innovation is increasingly shifting elsewhere.

Presenting the initiative, Health Commissioner Olivér Várhelyi, set out the scale of the challenge...

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending